Abstract
ABSTRACTTwo non-suppressed ion chromatographic (IC) methods, one with an anion and one with a cation separation column, were investigated for first time to determine cisplatin and carboplatin anticancer drugs using inductively coupled plasma–atomic emission spectrometry as a detector. The Shodex IC YK-421 (4.6 × 125 mm2) column was considered as the preferred separation column. The mobile phase in this case consisted of tartaric acid and boric acid. The flow rate was 1 mL/min and the injection volume was 20 μL. Separation was carried out in about 2 min with column temperature at 30°C after optimization. With cationic separation, the cisplatin elutes first, as opposed to the anionic one, where it elutes second. In addition, with both columns, a second peak for cisplatin appears which is attributed to a hydrolysis product of the drug. For the cation chromatographic method, the repeatability ranged from 3.1 to 5.9%, whereas the inter-day precision was 13.3 and 16.3% for cisplatin and carboplatin, respectively. The detection limits were 0.1 mg/ L Pt for both compounds. The proposed method was applied to the analysis of human urine with satisfactory recoveries indicating that there are no matrix effects.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
